Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

Adv Pharm Bull. 2020;10(2): 271-277. doi: 10.34172/apb.2020.032

PMID: 32373496 PMCID: PMC7191237

Research Article

A QSAR Study on the 4-Substituted Coumarins as Potent Tubulin Polymerization Inhibitors

Leila Dinparast ¹ , Siavoush Dastmalchi ^2,3,4 *

Cited by CrossRef: 2

1- Mądra-Gackowska K, Baumgart S, Jędrzejewski M, Studzińska R, Szeleszczuk Ł, Gackowski M. Computational QSAR study of novel 2-aminothiazol-4(5H)-one derivatives as 11β‐HSD1 inhibitors. J Comput Aided Mol Des. 2025;39(1) [Crossref]

2- Kamal A, Yakkala P, Soukya L, Begum S. In silico design strategies for tubulin inhibitors for the development of anticancer therapies. Expert Opinion on Drug Discovery. 2025;20(8):991 [Crossref]

3- Ahmadi S, Lotfi S, Azimi A, Kumar P. Multicellular target QSAR models for predicting of novel inhibitors against pancreatic cancer by Monte Carlo approach. Results in Chemistry. 2024;10:101734 [Crossref]

4- Sahu S, Ojha K. Applications of QSAR study in drug design of tubulin binding inhibitors. Journal of Biomolecular Structure and Dynamics. 2024;42(23):12806 [Crossref]